Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| Fibromüalgia mõju küsimustik× | Dermatology Life Quality Index× | |
|---|---|---|
| Valdkond | Tervisetulemid | Tervisetulemid |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta≠ | 1991 | 1994 |
| Looja≠ | Cynthia S. Burckhardt et al. | Andrew Y. Finlay and Gul K. Khan |
| Tüüp≠ | Self-report symptom and functional impairment questionnaire | Self-report quality of life questionnaire |
| Algallikas≠ | Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735. link ↗ | Finlay, A. Y., & Khan, G. K. (1994). Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use. Clinical and Experimental Dermatology, 19(3), 210-216. DOI ↗ |
| Rööpnimetused | FIQ, Fibromyalgia Impact, Fibromyalgia Questionnaire | DLQI, Finlay Index, Dermatology Quality of Life |
| Seotud≠ | 4 | 3 |
| Kokkuvõte≠ | The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice. | The DLQI is the primary patient-centered outcome measure in dermatology research and clinical practice. Developed by Andrew Finlay and Gul Khan in 1994, this 10-item self-report questionnaire quantifies the impact of skin disease on patients' daily functioning, emotional well-being, social relationships, and work capacity. It is simple, rapid, and applicable to virtually all dermatological conditions, making it the gold standard for assessing quality of life in dermatology. |
| ScholarGateAndmestik ↗ |
|
|